Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types

NCT06782412 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT06782412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Lead sponsor
KU Leuven
Phase
Phase 2/3
Overall status
Recruiting
Start date
February 6, 2025
Completion date
December 31, 2027
Enrollment
109 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fap, gastric cancer, oesophageal cancer, oncologic disorders, oncology, pancreatic ductal adenocarcinoma